RVL Pharmaceuticals plc (NASDAQ:RVLP) Q4 2022 Earnings Conference Call March 20, 2023 8:30 AM ET
Company Participants
Brian Markison - Chief Executive Officer
JD Schaub - Chief Operating Officer
Mike DePetris - Chief Financial Officer (interim)
Lisa Wilson - In-Site Communications
Conference Call Participants
Louise Chen - Cantor Fitzgerald
Douglas Tsao - HC Wainwright
Greg Fraser - Truist Securities
John Vandermosten - Zack’s
Unknown Analyst - Barclays
Glen Santangelo - Jefferies
Operator
Good morning everyone. My name is Shelby and I will be your conference Operator.
At this time, I’d like to welcome everyone to the RVL Pharmaceuticals fourth quarter and full year 2022 financial results call.
All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question and answer period. At that time, if you have a question, please press star and one on your telephone keypad. As a reminder, this conference call is being recorded today, March 20, 2023.
It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for RVL Pharmaceuticals. Please go ahead.
Lisa Wilson
Thank you Operator. Welcome to RVL Pharmaceuticals fourth quarter 2022 financial results and commercial update call. This is Lisa Wilson, Investor Relations for RVL. With me on today’s call are RVL’s Chief Executive Officer, Brian Markison, Chief Operating Officer, JD Schaub, and interim Chief Financial Officer, Mike DePetris.
This morning, the company issued a press release detailing financial results for the three months ended December 31, 2022. This press release and a webcast of this call can be accessed through the Investors section of the RVL website at rvlpharma.com.
Before we get started, I would like to remind everyone that any statements made on today’s conference call that express a belief, expectation, projection, forecast, anticipation or intent regarding future events and the company’s future performance may be considered forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are based on information available to RVL’s management as of today and involve risks and uncertainties, including those noted in this morning’s press release and the company’s filings with the Securities and Exchange Commission.
Such forward-looking statements are not guarantees of future performance. Actual results may differ materially from those projected in the forward-looking statements. RVL specifically disclaims any intent or obligation to update these forward-looking statements except as required by law.
During this call, we refer to non-GAAP financial measures such as adjusted EBITDA. For a reconciliation of adjusted EBITDA to net income or loss from continuing operations, please see the tables at the end of today’s press release.